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Background: Human mature oocytes are very susceptible to cryodamage. Several reports demonstrated that
vitrification might preserve oocyte better than slow freezing. However, this is still controversial. Thus, larger clinical,
biological and experimental trials to confirm this concept are necessary. The aim of the study was to evaluate and
compare fine morphological features in human mature oocytes cryopreserved with either slow freezing or
vitrification.
Methods: We used 47 supernumerary human mature (metaphase II) oocytes donated by consenting patients,
aged 27-32 years, enrolled in an IVF program. Thirtyfive oocytes were cryopreserved using slow freezing with 1.5 M
propanediol +0.2 M sucrose concentration (20 oocytes) or a closed vitrification system (CryoTip Irvine Scientific CA)
(15 oocytes). Twelve fresh oocytes were used as controls. All samples were prepared for light and transmission
electron microscopy evaluation.
Results: Control, slow frozen/thawed and vitrified/warmed oocytes (CO, SFO and VO, respectively) were rounded,
90–100 μm in diameter, with normal ooplasm showing uniform distribution of organelles. Mitochondria-smooth
endoplasmic reticulum (M-SER) aggregates and small mitochondria-vesicle (MV) complexes were the most numerous
structures found in all CO, SFO and VO cultured for 3–4 hours. M-SER aggregates decreased, and large MV complexes
increased in those SFO and VO maintained in culture for a prolonged period of time (8–9 hours). A slight to moderate
vacuolization was present in the cytoplasm of SFO. Only a slight vacuolization was present in VO, whereas vacuoles
were almost completely absent in CO. Amount and density of cortical granules (CG) appeared abnormally reduced in
SFO and VO, irrespective of the protocol applied.
Conclusions: Even though, both slow freezing and vitrification ensured a good overall preservation of the oocyte,
we found that: 1) prolonged culture activates an intracellular membrane “recycling” that causes the abnormal
transformation of the membranes of the small MV complexes and of SER into larger rounded vesicles; 2) vacuolization
appears as a recurrent form of cell damage during slow freezing and, at a lesser extent, during vitrification using a
closed device; 3) premature CG exocytosis was present in both SFO and VO and may cause zona pellucida hardening.
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Thanks to the important technological advances obtained
in the last two decades, human oocyte cryopreservation is
today one of the techniques of choice in clinical practice. In
respect to embryo cryopreservation, oocyte cryopreserva-
tion may be applicable even in absence of a male partner.
In addition, oocyte freezing may circumvent ethical or
legal considerations associated with embryos [1]. However,
although the first human live birth from cryopreserved
oocytes was reported more than twenty years ago [2],
nevertheless the success rates in assisted reproductive
technologies using frozen oocytes have lagged behind
those using frozen embryos, most likely as a result of the
biochemical and physical properties of the oocyte.
Cell survival after freezing is intimately associated with
the composition and the permeability characteristics of
the cell membrane, the surface to volume ratio of the cells,
and the difference in osmotic pressure between the two
sides of the membranes [3,4]. Additional factors associated
with oocyte survival and developmental competence after
freezing include developmental stage at freezing (isolation
at the germinal vesicle – GV -, meiotic metaphase I, vs.
meiotic metaphase II – MII - stages of development),
cryoprotectant type and concentration and, the method or
“protocol” of cryopreservation. Oocyte survival with a
specific protocol can also vary according to species. This
is mainly related to the oocyte size, but also biochemical
properties contribute to such an outcome. Mature MII
oocytes, commonly used for cryopreservation, are among
the largest cells in the human body and contain the deli-
cate meiotic spindle. As their cytoplasm contains a high
proportion of water in comparison to other cells, damage
due to ice crystal formation was a mandatory problem to
overcome to achieve viability after thawing [5,6]. Protocols
that include dehydration of oocytes before and/or during
the cooling procedure reduced ice crystal formation and
improved clinical outcomes [7]. Cryopreservation of ma-
ture oocytes may cause hardening of the zona pellucida
(ZP), impairing fertilization [8]; however, intracytoplasmic
sperm injection (ICSI) may be applied for overcoming this
problem [9].
Up to date, the two most common freezing protocols
used are slow freezing and vitrification [10]. In slow
freezing protocol, the oocytes are gradually frozen (con-
trolled rate freezing) in the presence of low concentrations
of cryoprotectants, which reduce the risk of intracellular
ice formation. On the contrary, the vitrification method
combines ultrarapid cooling with minimum volume and
high concentration of cryoprotectants, avoiding the for-
mation of ice crystals, and thus giving to the vitrification
solution a transparent, glass-like appearance [7].
In the last years, each protocol showed outcome im-
provement [11,12], although cell damage resulted lower
after vitrification in some reports [13,14]. Indeed, largercontrolled clinical, biological and experimental trials are
necessary to eventually confirming these data. In particu-
lar, it is still controversial the opportunity of using open
devices versus closed devices for vitrification [15-18]. Open
devices seem superior to closed ones, at least according to
the little morphological data available [19].
Evaluation of oocyte quality after cryopreservation is
based mainly on the morphological appearance of the
oocyte [20]. Phase contrast microscopy (PCM) is cur-
rently used for scoring oocyte and embryo quality. How-
ever, a good survival as evaluated by standard PCM is
not necessary related to a good performance of the cell
in giving a competent embryo. At this extent, the use of
electron microscopy (EM) to evaluate fine morpho-
logical damage is a tool to assess oocyte quality to a
higher sensible level. Transmission electron microscopy
(TEM), especially when associated with a morphometric
analysis, allows an accurate evaluation of fine details of
cell microanatomy that can be compromised during the
cryopreservation procedures [21-27].
The aim of this study was to compare the effects of
slow freezing and vitrification with a closed device on
the quality of the oocyte. In this article, we report corre-
lated light microscopy (LM) and TEM observations and
morphometric data on the fine morphology of human
fresh and cryopreserved MII oocytes.
Methods
Source of oocytes
This project has been approved by our internal review
board and the Italian Ministry of Health. The study in-
volves patients who decided to donate their super-
numerary eggs to research between January 2012 and
January 2013. The age of women ranged from 27 to
32 years old, and their infertility was due to male, tubal
factors or idiopathic issues. Patients with endometriosis
or other conditions, that could influence oocyte quality,
were excluded from the study. Ovarian stimulation was
induced with a long protocol using GnRH agonist and
rFSH, according to previous clinical report [28]. HCG
(10,000 IU) was injected 36 hours before retrieval. Oocytes
were cultured in fertilization media for at least 2 hours
(Cook IVF, Brisbane, Australia) before cumulus/corona
cells complete removal; this was performed enzymatically
(hyaluronidase 20–40 IU/ml) and mechanically (using fine
pipettes Flexi pipette Cook). Mature oocytes displaying a
1st polar body (PB) with a clear cytoplasm were assigned
to either the fresh control or study groups. Fresh control
oocytes (CO) were fixed after a period of 3–4 hours
following retrieval. Cryopreservation was performed
within 3–8 hours after retrieval according to the labora-
tory workload. Slow frozen/thawed (SFO) and vitrified/
warmed oocytes (VO) were cultured for a further hour
before fixation.
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Oocytes were cryopreserved using a slow-freezing protocol
adapted from the one originally described for embryos [29].
Eggs were equilibrated in one step homemade solution
containing 1.5 mol/L 1,2-propanediol (PrOH) supple-
mented with 20% of synthetic serum supplement (SSS)
(Irvine Scientific, Santa Ana, CA, USA) for 10 minutes
then transferred for 5 minutes into a loading solution con-
taining 1.5 mol/L PrOH +0.2 mol/L sucrose +20% SSS.
Afterwards the oocytes were loaded into plastic straws
(Paillettes Crystal 133 mm; CryoBioSystem, Paris, France)
and placed into an automated Kryo 10 series III biological
freezer (Planer Kryo 10/1,7 GB; Planer, Surrey, UK). All
the procedures were carried out at room temperature
(around 25°C). Once the loaded straws were placed in
the machine the temperature was gradually lowered
from 20°C to −7°C at a rate of −2° C/min. Manual seeding
was induced during a 10 minutes holding ramp at −7°C.
The temperature was then decreased to −30° C at a rate
of −0.3°C/min and finally rapidly to −150° C at a rate
of −50°C/min. The straws were then plunged into liquid
nitrogen and stored for later use. For the thawing proce-
dures the straws were air-warmed for 30 seconds and
then placed in a 30°C water bath for 40 seconds. The
cryoprotectant was removed by stepwise dilution of
PrOH at room temperature. The thawing solutions were
homemade and contained:
a) 1.0 mol/L PrOH +0.3 mol/L sucrose +20% SSS
(5 minute equilibration)
b) 0.5 mol/L PrOH +0.3 mol/L sucrose +20% SSS
(5 minute equilibration)
c) 0.3 mol/L sucrose +20% SSS (10 minute exposure
before the final dilution in PBS solution for another
10 minutes).
Survived oocytes were finally placed in culture in
Cleavage medium (Cook) at 37°C and 5% CO2 and re-
checked 1 hour later to confirm their good status prior
to fixation.
Vitrification-warming procedure
Oocytes were vitrified using commercial kits (Irvine
Scientific CA) and closed vitrification devices (CryoTip).
The oocytes were washed in a drop of hepes-buffered
medium (gamete buffer Cook) and, subsequently in
three drops of equilibration solution containing ethyl-
ene glycol (EG) (7.5% vol/vol) and dimethylsulphoxide
(DMSO) (7.5% vol/vol). After 8 minutes, eggs were
transferred into a vitrification solution drop containing
15% vol/vol EG, 15% vol/vol DMSO, and 0.5 mol/L su-
crose, for a total of 20 seconds before being loaded into
a Cryotip and sealed properly at both ends. The device
was directly plunged into liquid nitrogen and stored.Oocytes were rapidly warmed by transferring the Cryotip
directly from liquid nitrogen to a 37°C water bath for
3 seconds. The device was cut at the end and the oocyte/s
released in a thawing solution (1.0 mol/L sucrose) for a
minute then moved to a dilution media (0.5 mol/L
sucrose) for 4 minutes and finally washed twice in a wash-
ing solution (6 minutes). Survived oocytes were cultured
in Cleavage medium (Cook) before the fixation.
Electron microscopy
Fortyseven supernumerary human MII oocytes (12 CO,
20 SFO and 15 VO) were donated by consenting pa-
tients (N = 12), and included in this study. In detail: 3
patients donated 12 CO (4 oocytes from each patient), 5
patients donated 20 SFO (2, 3, 4, 5, 6 oocytes respectively
from each patient), 4 patients donated 15 VO (1, 3, 6, 5
oocytes respectively from each patient).
Only oocytes that appeared of good quality when ob-
served by PCM after thawing or warming were selected
for EM evaluation. They should have: 1. a rounded,
regular shape; 2. a clear, moderately granular cytoplasm;
3. a narrow perivitelline space (PVS) with the 1st PB
and, 4. an intact, colorless ZP [30].
Oocytes were fixed and processed for LM and TEM
analysis as follows. Oocyte fixation was performed in 1.5%
glutaraldehyde (SIC, Rome, Italy) in PBS solution. After
fixation for 2–5 days at 4°C, the samples were rinsed in
PBS, post-fixed with 1% osmium tetroxide (Agar Scientific,
Stansted, UK) in PBS, and rinsed again in PBS. Oocytes
were then embedded in small blocks of 1% agar of about
5×5×1 mm in size, dehydrated in ascending series of etha-
nol (Carlo Erba Reagenti, Milan, Italy), immersed in propyl-
ene oxide (BDH Italia, Milan, Italy) for solvent substitution,
embedded in epoxy resin (Electron Microscopy Sciences,
Hatfield, PA, USA) and sectioned by a Reichert-Jung
Ultracut E ultramicrotome. Semithin sections (1 μm thick)
were stained with toluidine blue, examined by LM (Zeiss
Axioskop) and photographed using a digital camera (Leica
DFC230). Ultrathin sections (60–80 nm) were cut with a
diamond knife, mounted on copper grids and contrasted
with saturated uranyl acetate followed by lead citrate (SIC,
Rome, Italy). They were examined and photographed
using a Zeiss EM 10 and a Philips TEM CM100 Electron
Microscopes operating at 80KV. Images were acquired
using a GATAN CCD camera.
According to Nottola et al. [23], as reviewed by Khalili
et al. [26], the following parameters have been evaluated
by LM and TEM and taken into consideration for the
qualitative morphological assessment of the ultrastructural
preservation of oocytes: main characteristics (including
shape and dimensions), ZP texture, PVS appearance,
integrity of the oolemma, microtopography, type and
quality of the organelles, presence and extent of ooplasmic
vacuolization.
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PVS and the arrangement of the MII spindle were not
systematically assessed, due to their detection only in
sections laying on appropriate planes.
Statistical analysis
The presence of vacuoles ≥1 μm was evaluated at the LM
level on at least 3 equatorial sections per oocyte (distance
between the sections: 3–4 μm), and values were expressed
in number of vacuoles per 100 μm2 of the oocyte area. The
evaluation of cortical granule (CG) density was performed
through collection of TEM microphotographs of the entire
surface profiles at a magnification of 6300X on 3 equatorial
sections per oocyte. Images were further enlarged on the
PC screen, in order to easily recognize and count CG.
Values were expressed in number of CG per 10 μm of the
oocyte linear surface profile [23].
Authors presented statistical data as a mean value ±
standard deviation (SD); P value and significance were
evaluated using Student’s t test (www.graphpad.com/
quickcalcs, last access: September 2, 2014). The cut off
for significance was P < 0.05.
Results
Main characteristics
LM and TEM techniques allowed analyzing and compar-
ing size, shape and organelle distribution in CO, SFO
and VO. CO, SFO and VO were all generally rounded,
90–100 μm in diameter, with normal ooplasm showing
uniform distribution of organelles. All CO, SFO and VO
showed an intact ZP, separated by a narrow PVS from
the oolemma, continuous and provided with microvilli
(Figure 1a, b, c, d, e and f ).
Only in favorable sections, the 1st PB was detected by
LM in the PVS (which appeared wider in this region)
(Figure 1a). The MII spindle (or a portion of this) was
also visible in the ooplasm of a number of CO (N = 4),
SFO (N = 6) and VO (N = 5), assuming a peripheral pos-
ition (Figure 1b). By TEM, the 1st PB contained condensed
chromatin, mitochondria, residual microtubules and scat-
tered CG. The MII spindle consisted of chromosomes, with
a dense granulo-fibrillar microstructure, and associated mi-
crotubules converging at each pole (data not shown).
Mitochondria-smooth endoplasmic reticulum aggregates
and mitochondria-vesicle complexes
Using TEM, the most numerous organelles found in all the
CO, SFO and VO cultured for 3–4 hours, consisted of ag-
gregates of anastomosing tubuli of smooth endoplasmic
reticulum (SER) surrounded by mitochondria (M-SER
aggregates). The diameter of the tubular network of the
M-SER aggregates varied from 1 to 5 μm (Figure 2a and b).
Small vesicles, 0.3 – 0.5 μm in diameter, containing a
slighlty electrondense material were associated withmitochondria forming the so-called mitochondria-vesicle
(MV) complexes (Figure 2b). No overt qualitative differ-
ences in the fine structural morphology of M-SER aggre-
gates and MV complexes came out from the comparison
among CO, SFO and VO after 3–4 hours of culture.
M-SER aggregates appeared instead partially replaced by
numerous, large MV complexes, up to 2.5 μm in vesicle
diameter, when SFO and VO extended culture for a pro-
longed period of time (8–9 hours) (Figure 2c and d).
Mitochondria, either associated with membranes or iso-
lated, revealed a normal fine structure in all the samples
observed (CO, SFO and VO). They were rounded or
oval in profile, with a diameter varying from 0.5 to
0.8 μm and a few peripheral arch-like or transverse cris-
tae and contained a moderately electrondense matrix
(Figure 2a, b and d; Figure 3c).
Vacuoles
LM showed very rare vacuolization of the ooplasm in CO
(Figure 1a). TEM confirmed the very sporadic incidence of
vacuolization in these oocytes (Figure 1d). A slight to mod-
erate vacuolization was found in the cytoplasm of cryopre-
served oocytes, more pronounced in SFO than in VO
(Figure 1b and e; Figure 3a, b and c). Vacuoles, varying in
diameter from 0.2 to about 2.5 μm, were apparently empty
(Figure 3a,b and c) or contained cell debris (Figure 3a
and b). Vacuole membrane was often discontinuous
(Figure 3a, b and c). Sometimes, secondary lysosomes
and/or multivesicular bodies (MVBs) associated with vac-
uoles were present (Figure 3c). Otherwise, it was usually
detected a normal pattern of organelles in the cytoplasmic
areas adjacent to vacuoles (Figure 3b and c).
The morphometric analysis performed on fresh and cryo-
preserved oocytes belonging to both study groups (i.e. sub-
jected to slow freezing or vitrification with a closed system)
revealed that the difference in vacuole number between CO
and SFO was statistically significant. In particular, the mean
number ± SD of vacuoles ≥1 μm in diameter per 100 μm2
was 0.40 ± 0.12 and 2.09 ± 0.85 in CO and SFO, respectively
(P < 0.0001) (Table 1). A statistically significant difference in
vacuole number between CO and VO was also present. In
fact, the mean number ± SD of vacuoles ≥1 μm in diameter
per 100 μm2 was 0.40 ± 0.12 and 0.85 ± 0.37 in CO and
VO, respectively (P = 0.0005) (Table 1). However, we found
a significant difference in vacuole number also between
SFO and VO (P < 0.0001), confirming the presence of more
vacuoles in SFO than in VO (Table 1).
Cortical granules
In fresh oocytes (CO) the cortex was rich in CG aligned
in a continuous array, at the periphery of oocyte, under
the oolemma. CG were rounded and showed a diameter
varying from 300 to 400 nm (Figure 4a). CG formed in-
stead a discontinuous layer and represented less in both
Figure 1 (See legend on next page.)
Bianchi et al. Reproductive Biology and Endocrinology 2014, 12:110 Page 5 of 13
http://www.rbej.com/content/12/1/110
(See figure on previous page.)
Figure 1 Human CO, SFO and VO at MII stage. Main characteristics. By LM (a-c) and TEM (d-f) no overt difference in shape, dimensions and
organelle distribution is seen among CO (a,d), SFO (b,e) and VO (c,f). Note the intact ZP (a-c) and the presence of microvilli (mv) on the
oolemma (d-f). Numerous vacuoles (Va) are seen in SFO (b,e). O: oocyte; PB: 1st PB; arrow: MII spindle with chromosomes. Bar is: 45 μm (a-c);
5 μm (d-f).
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The mean number ± SD of CG per 10 μm was 8.10 ±
1.59, 2.95 ± 0.96, and 2.40 ± 0.84 in CO, SFO and VO,
respectively. These differences between fresh and cryo-
preserved groups were highly significant (CO and SFO:
P < 0.0001; CO and VO: P < 0.0001). On the contrary, we
did not find any significant difference in amount of CG
between SFO and VO (P = 0.086) (Table 2).
Discussion
Despite over the last 10 years several satisfactory results
have been published, yet there is not a defined, generally
accepted approach that guarantees a safe routine appli-
cation of cryopreservation.
As above introduced, the two main protocols applied
in the literature are the slow freezing and the vitrifica-
tion (with open or closed systems) [1].
The cryobiology of slow freezing was based on a slow
cooling/rapid thawing method that had already been ap-
plied successfully for embryo cryopreservation. All the
improvement concerning this technique were mainly fo-
cused on the cryoprotectant choice and concentration or
the exposure time. The freezing curve has not been
changed since the first one designed by Lassalle for em-
bryo freezing [29]. The most significant difference in
survival and clinical results seems to be the amount of
sucrose used during the freezing and thawing. In detail,
a low concentration of sucrose (0.1 mol/L) led to poor
survival rates (around 40%) [31]; instead, increasing the
amount of sucrose up to 0.3 mol/L significantly im-
proved post-thaw survival rates but implantation and
pregnancy rates were low [28,32]. Bianchi et al. [11,33]
proposed a modified protocol that used a thawing solu-
tion in which sucrose concentration was higher than in
the freezing solution (0.3 mol/L and 0.2 mol/L respect-
ively). The application of this protocol yielded to better
outcome rates (survival rates around 70-80% with a 20%
pregnancy rate) in comparison with those obtainable
with the above described protocols. This improvement is
probably related to the more adequate dehydration
achieved with 0.2 mol/L sucrose in the freezing solution
compared to 0.1 mol/L or 0.3 mol/L. In addition, the
higher (0.3 mol/L) sucrose concentration used during
thawing leads to a better controlled water exchange be-
tween the inside and outside of the cell stabilizing the
membrane and thus avoiding shrinkage.
Conversely, even though the first report of vitrification
in embryology was back in 1985 [34], the generalapplication of vitrification in assisted reproduction has
been rather limited until recently. Numerous recent
publications have shown outstanding results for survival
and clinical outcomes using vitrification compared to
slow cooling [35-37]. Vitrification methods have been
modified over the years to optimize results in humans,
by using minimal volumes and very rapid cooling rates,
allowing for lower concentrations of cryoprotectants to
reduce injuries related to chemical toxicity, osmotic
shock, chilling sensitivity and ice nucleation [38,39]. The
use of open carrier devices for vitrification can make a
difference on survival rates but sometime they cannot be
used due to possible contamination issues. In the open
system, in fact, the specimen is in direct contact with li-
quid nitrogen and this may cause cross contamination
even though very unlikely. The closed system is consid-
ered safer [17,18,40], but slows down the cooling
temperature and can reduce the survival rate after thaw-
ing, although the replacement of the open vitrification
system with a closed system has been reported to have
no impact on fertilization, implantation and clinical
pregnancy rates [18,41]. European Union directives on
tissue manipulation have been issued by the European
Parliament to increase the safety and quality of tissues—
including reproductive cells—processed for human re-
implantation through the control of equipment, devices,
and environment. In these directives, there are no spe-
cific indications against direct contact between tissue/
cells and liquid nitrogen. Therefore, both open and
closed systems comply with European Union directives,
as long as aseptic procedures during vitrification-
cryostorage-warming are established [16].
In the present study, we evaluated and compared the
structural and ultrastructural morphology of human
fresh and cryopreserved MII oocytes. Cryopreservation
was performed by slow freezing, with PrOH and sucrose
(0.2 mol/L in the freezing solution and 0.3 mol/L in the
thawing solution), and by vitrification, using a closed
device.
Main characteristics
All CO, SFO and VO appeared normal in shape, dimen-
sions and texture of the ooplasm under LM and low
magnification TEM examination. This features are super-
imposable to those described in our previous reports on
human mature oocytes subjected to different protocols of
slow cooling [21,22,25] or vitrification [23,42], reinforcing
the concept that current cryopreservation protocols,
Figure 2 Human CO, SFO and VO at MII stage. M-SER aggregates and MV complexes. By TEM, voluminous M-SER aggregates are seen in (a) (CO)
and (b) (SFO cultured for 3–4 hours). Small MV complexes are also observable in (b). M-SER appear partially replaced by numerous and larger MV
complexes after prolonged culture, as seen in (c,d) (VO cultured for 8–9 hours). Mitochondria (M) are well preserved in both SFO (b) and VO (d). Bar is:
1 μm (a,b,d); 2 μm (c).
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device, do not produce major alterations in the oocyte
microdomains.
In our study, when observable in sections laying on ap-
propriate planes, the MII spindle appeared regularly shaped
and properly positioned not only in the ooplasm of CO butalso in that of SFO and VO, confirming that meiotic spin-
dle alterations eventually occurring during cryostorage
(both slow freezing and vitrification) can be reversed on
rewarming [43]. However, due to specific technical require-
ments and to the actual difficulty to fully visualize the
spindle scaffolding and associated chromosomes in TEM
Figure 3 (See legend on next page.)
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Figure 3 Human SFO and VO at MII stage. Presence of vacuoles. By TEM, numerous vacuoles (Va) are seen in the ooplasm of SFO (a,b), whereas only
a few vacuoles are visible in VO (c). Vacuoles appear empty (a-c) or contain cell debris (a,b). Note some interruptions in the vacuole membrane (a-c).
A close association between a vacuole and a lysosome (Ly) is seen in (c). A typical M-SER aggregate (b), isolated mitochondria (M) and MV complexes
(c) are seen in the areas adjacent to vacuoles. Bar is: 1 μm (a-c).
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structural tools, such as confocal laser microscopy, more
suitable than TEM for studying spindle morphodynamics
during cryopreservation [21].
The finding in both SFO and VO of a good preserva-
tion of mitochondrial structure, as in our previous stud-
ies [21-23,25,42] further emphasizes that both slow
freezing and vitrification with a closed device do not
produce marked and diffuse alterations in the oocyte
microstructure. This does not confirm what reported by
other Authors, who described alterations in mitochondrial
matrix and cristae in a percentage of oocytes cryopre-
served with both slow cooling and vitrification [19,44].
Due to the many differences among protocols and tech-
nique of sampling, it is not possible to hypothesize here an
explanation, but this aspect deserves further evaluation.
Mitochondria-smooth endoplasmic reticulum aggregates
and mitochondria-vesicle complexes
We found that M-SER aggregates and small MV com-
plexes were the most common organelles found in all
the oocytes cultured for 3–4 hours, both fresh and cryo-
preserved, with either slow freezing or vitrification.
Small MV complexes, isolated SER tubules and/or SER
networks are present in human immature, GV-stage
oocytes [42,45]. Only mature, MII oocytes show fully or-
ganized M-SER aggregates of various sizes. These aggre-
gates, according to the biochemical needs of the mature,
healthy oocyte, may regulate calcium levels and mitochon-
drial ATP production, thus potentially contributing to the
modulation of calcium-dependent signal transduction
pathways at fertilization [46]. M-SER aggregates may have
a role in production of substances useful at fertilization
and/or in rapid neoformation of nuclear and cytoplasmic
membranes during early embryogenesis [47-49].
We did not find evident qualitative differences in the
fine structural morphology of M-SER aggregates andTable 1 Morphometric evaluation of the presence and
extent of vacuolization in human MII oocytes subjected
to slow freezing and vitrification with a closed device
Fresh
controls
(CO)
Cryopreserved
Slow frozen/
thawed (SFO)
Vitrified/
warmed (VO)
N° of vacuoles/100 μm2
(vacuole diameter ≥1 μm)
0.40 ± 0.12a 2.09 ± 0.85b 0.85 ± 0.37c
Values are expressed as mean ± SD. Statistical analysis is calculated between
columns. Differences in values were considered significant if P <0.05.
a,bP <0.0001; a,cP = 0.0005; b,cP <0.0001.MV complexes in both SFO and VO, when compared to
CO, after 3–4 hours of culture. In other reports, a per-
centage of human oocytes, vitrified with open devices,
showed small and slender M-SER aggregates [23]. Differ-
ently, previous studies on oocytes subjected to slow
freezing and treated with PrOH did not evidence any
ultrastructural change of these aggregates in respect to
fresh controls [21,25].
In the present study, we also considered the amount of
M-SER aggregates, evidencing that they were partially re-
placed by larger MV complexes in the oocytes maintained
in culture for a prolonged period of time (8–9 hours),
either SFO or VO. This particular feature, led us to
hypothesize that prolonged culture may induce an intra-
cellular membrane “recycling”, causing a discrete enlarge-
ment of the MV complexes to which also contribute a
considerable SER membrane reassembly. The presence of
numerous and large MV complexes was previously de-
scribed in MII oocytes kept in vitro for 24 (oocytes aged
in vitro [50]) or 48 hours (oocytes insemined but not fer-
tilized [47]). Large MV complexes are also present in GV
oocytes that have reached MII stage after 24 hour-culture
(in vitro matured oocytes [27]). Therefore, changes of MV
complexes and SER do not seem related only to the ma-
turative stage of the oocyte at the beginning of the culture,
but mainly to the culture period. In the present study, we
originally demonstrated that abnormally large MV com-
plexes may form very early during culture, being already
present 8–9 hours after oocyte retrieval. The role of these
structures is still unknown. We may speculate that they
may be associated to impairment of calcium homeostasis,
thus reducing the oocyte competence for fertilization after
a prolonged culture.
Vacuoles
In our study, a slight to moderate vacuolization was
present in the cytoplasm of SFO. Only a slight vacuoliza-
tion was instead present in VO. Vacuoles were almost
completely absent in CO.
Vacuolization is an important dysmorphism constantly
detected in human mature oocytes treated with different
protocols of slow freezing [21,22,25,44,51]. This is explain-
able as a non-specific response of the oocyte to thermal, os-
motic and/or chemical injuries that may occur during
cryopreservation. We observed an association of vacuoles
with lysosomes and MVBs that are types of organelles
rarely present in human healthy mature oocytes and of de-
generative significance [44]. The appearance of vacuoles in
Figure 4 Human CO, SFO and VO at MII stage. CG distribution. By TEM, a rim of CG is seen just beneath the oolemma of a CO (a). CG appear
instead sparse or isolated forming a discontinuous layer in both SFO (b) and VO (c). mv: oocyte microvilli. Bar is: 1 μm (a-c).
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Table 2 Morphometric evaluation of the amount of CG in
human MII oocytes subjected to slow freezing and
vitrification with a closed device
Fresh
controls
(CO)
Cryopreserved
Slow frozen/
thawed (SFO)
Vitrified/
warmed (VO)
N° of CG/10 μm 8.10 ± 1.59a 2.95 ± 0.96b 2.40 ± 0.84c
Values are expressed as mean ± SD. Statistical analysis is calculated between
columns. Differences in values were considered significant if P <0.05.
a,bP <0.0001; a,cP <0.0001; b,c P = 0.086*.
*not significant.
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fertilizability and with an impairment of embryo develop-
ment [52]. The opinions about the presence and extent of
vacuolization in human VO are controversial. In fact, some
Authors reported an evident vacuolization in oocytes vitri-
fied with both closed (Cryotip) and open (Cryotop) devices
[19,42,44]. Vacuolization, however, was more severe when a
closed device was applied. This may be due to the Cryotip
thermosealing and/or to the longer time for closed-
vitrification oocyte discharge into the warming solution
[19]. In our previous studies, we instead referred a virtual
absence of vacuolization in oocytes vitrified using different
open devices (Cryoleaf and Cryoloop) [23]. Taken together,
all these data suggest the occurrence of a possible
cryodevice-dependant vacuolization, that may be also asso-
ciated to the skill of the operator and even to the sample
processing for EM. The different morphometric approaches
in vacuole counting and measuring should be also taken
into consideration [42]. Our results on SFO well correlate
with the data of the recent literature on oocyte cryopreser-
vation, confirming the association between slow freezing
and occurrence of vacuolization in the oocyte. We also
found only a slight vacuolization in all the VO, significantly
lesser than that observed in SFO. Thus our morphometric
results, differently from previous qualitative observations,
failed in demonstrating a severe incidence of vacuolization
in oocytes vitrified with a closed device.
Cortical granules
We found that amount and density of CG appeared ab-
normally reduced in both SFO and VO, in comparison
with CO.
Usually, CG are regularly present, stratified in one to
three rows, in the subplasmalemmal areas of mature
oocytes of most mammalian species including humans
[47]. They are Golgi-derived, membrane-bounded organ-
elles formed during the early stages of oocyte growth and
contain glycosaminoglycans, proteases, acid phosphatases
and peroxidases [53]. At fertilization, CG content is sud-
denly and massively exocytosed by the activated oocyte in
the PVS (‘cortical reaction’), leading to a hardening of
the inner face of the ZP (‘zona reaction’) and to aconsequent inhibition of eventual penetration of super-
numerary spermatozoa into the oocyte (polyspermy)
[54,55]. Calcium transients at fertilization seem involved
in triggering CG fusion with the oolemma, resulting in the
release of their contents into the PVS [56]. Our findings,
are comparable to previous studies on slow freezing
[21,22,25,44,51] and vitrification [19,23,42,44], and sug-
gest that a precocious oocyte activation may occur
during cryopreservation, irrespective of the protocol ap-
plied (slow freezing or vitrification, even with a closed
device). This activation leads to a premature CG exocyt-
osis and a consequent diffuse hardening of the ZP, thus
greatly impairing oocyte competence to fertilization.
Conclusions
In conclusion, in this study, human MII oocytes fine
structure appeared generally tolerant to both slow freez-
ing and vitrification with a closed system, showing fairly
good morphological preservation. However, the appear-
ance of large MV complexes in place of M-SER aggre-
gates in the ooplasm just after 8–9 hours of culture
suggests to avoiding extension of culture for human MII
oocytes even for a limited number of hours. In addition,
the presence of numerous vacuoles in SFO and of only
scarce vacuoles in VO implies a different sensitivity of
these two groups of oocytes to cryodamage and a better
preservation of native oocyte structure after vitrification,
even if with a closed system. Thus, in our opinion, vitri-
fication protocol – not only based on open systems, as
previously reported by our group, but also employing
closed devices - seems to be more effective than slow
freezing in preserving oocyte microstructural integrity.
Finally, our data support the notion that CG are partially
lost during oocyte cryopreservation, irrespective of the
protocol applied (slow freezing or vitrification), recom-
mending the use of ICSI as the preferred method of in-
semination for these oocytes.
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